This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Enzon Pharmaceuticals Inc (ENZN)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 34.56M 6.52M 77.35M 104.32M
Receivables 0.00 0.00 0.00 0.00
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 478.00K 601.00K 1.90M 2.75M
Total Current Assets 35.04M 7.12M 198.64M 165.26M
Property, Plant & Equipment, Gross 0.00 0.00 26.92M 57.38M
Accumulated Depreciation & Depletion 0.00 0.00 25.78M 40.57M
Property, Plant & Equipment, Net 0.00 0.00 1.14M 16.80M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 0.00 0.00 0.00 161.15M
Total Non-Current Assets 0.00 0.00 1.14M 177.95M
Liabilities & Shareholder Equity
Total Assets 35.04M 7.12M 199.78M 343.21M
Accounts Payable 181.00K 93.00K 776.00K 1.57M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 194.00K 0.00 0.00 0.00
Total Current Liabilities 5.06M 1.31M 122.31M 15.26M
Long Term Debt 0.00 0.00 0.00 129.50M
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 381.00K 558.00K 0.00 1.26M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 381.00K 558.00K 0.00 130.76M
Total Liabilities 5.44M 1.87M 122.31M 146.03M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 29.60M 5.26M 77.47M 197.18M
Common Par 441.00K 441.00K 437.00K 483.00K
Additional Paid In Capital 130.06M 134.51M 224.80M 341.76M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -100.90M -129.70M -147.85M -145.06M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 0.00 0.00 83.00K 3.00K
Total Capitalization 29.60M 5.26M 77.47M 326.68M
Total Equity 29.60M 5.26M 77.47M 197.18M
Total Liabilities & Stock Equity 35.04M 7.12M 199.78M 343.21M
Total Common Shares Outstanding 44.17M 44.09M 43.67M 48.29M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 44.12M 43.78M 46.74M 51.91M
Diluted Weighted Shares Outstanding 44.24M 51.04M 46.74M 51.91M
Number of Employees 1 1 21 72
Number of Part-Time Employees 0 0 0 0

ENZN Enzon Pharmaceuticals Inc

Chart of ENZN

Analysts Ratings for ENZN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

ENZN Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs